catechin has been researched along with Diabetic Cardiomyopathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, Q; Li, Y; Mehmood, S; Yang, R | 1 |
| Chen, TS; Huang, CY; Kuo, CH; Kuo, WW; Liou, J; Liou, SY; Padma, VV; Pan, LF; Yao, CH; Yeh, YL | 1 |
| Abukhalil, MH; El-Missiry, MA; El-Sawi, MR; Othman, AI | 1 |
| Abukhalil, MH; Al Hroob, AM; Hussein, OE; Mahmoud, AM | 1 |
| Cai, Q; Cheng, M; Gao, HQ; Li, BY; Li, XL; Luan, SS; Qin, RJ; Yin, WB; Yu, F | 1 |
| Chen, C; Guo, J; Han, Y; He, D; Jiang, B; Sun, H; Yang, J; Yu, C; Zeng, C; Zhou, L | 1 |
1 review(s) available for catechin and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate.
Topics: Animals; Antioxidants; Catechin; Diabetic Cardiomyopathies; Humans; Oxidative Stress; Polyphenols; Tea | 2019 |
5 other study(ies) available for catechin and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hydroxyproline; Hypertrophy; Mammals; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microtubule-Associated Proteins; Rats; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2022 |
Green tea epigallocatechin gallate enhances cardiac function restoration through survival signaling expression in diabetes mellitus rats with autologous adipose tissue-derived stem cells.
Topics: Adipose Tissue; Administration, Oral; Animals; Apoptosis; Biomarkers; Blood Glucose; Catechin; Cell Survival; Cells, Cultured; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Male; Myocytes, Cardiac; Rats, Wistar; Recovery of Function; Signal Transduction; Stem Cell Transplantation | 2017 |
Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Apoptosis; Biomarkers; Cardiotonic Agents; Catechin; Cytokines; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Male; Myocardium; Niacinamide; Oxidative Stress; Rats, Wistar; Risk Factors; Streptozocin | 2017 |
Quantitative proteomics study of protective effects of grape seed procyanidin B2 on diabetic cardiomyopathy in db/db mice.
Topics: Animals; Antioxidants; Apoptosis; Biflavonoids; Catechin; Diabetic Cardiomyopathies; Evaluation Studies as Topic; Grape Seed Extract; Male; Mice; Oxidative Stress; Proanthocyanidins; Protective Agents; Proteomics | 2014 |
(-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings.
Topics: Camellia sinensis; Catechin; Cell Line; Cell Proliferation; Diabetic Cardiomyopathies; Down-Regulation; Glucose; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Plant Extracts; Protein Kinase C | 2011 |